Literature DB >> 16024722

TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia.

Janet S Lee1, Charles W Frevert, Gustavo Matute-Bello, Mark M Wurfel, Venus A Wong, Shu-Min Lin, John Ruzinski, Steve Mongovin, Richard B Goodman, Thomas R Martin.   

Abstract

We examined the role of Toll-like receptor (TLR)-4 in modifying the lung inflammatory response and its effects on the bacterial recovery from the lungs following inhaled Escherichia coli in two different strains of TLR-4 mutant mice that are hyporesponsive to LPS. The C57BL/10ScN(tlr4(lps-del)) mice containing a deletion mutation in the TLR-4 gene showed lower proinflammatory cytokine levels, lower lung MPO activity, and less parenchymal and peribronchial inflammation compared with the C57BL/10ScSn mice, a related TLR-4 wild-type substrain. However, the C57BL/10ScN(tlr4(lps-del)) mutant showed lower bacterial recovery in the lungs following inhaled E. coli associated with a rapid but transient increase in air space neutrophil counts at 6 h. In comparison, the C3H/HeJ(tlr4(Lps-d)) mutant mice containing a Pro712His substitution in TLR-4 demonstrated lower proinflammatory cytokine levels, lower lung MPO activity, and lower neutrophil accumulation in the air spaces but showed no differences in the bacterial burden of inhaled E. coli at 6 h, when compared with the TLR-4 wild-type C3H/HeSnJ mice. Thus two different TLR-4 mutants showed attenuated inflammatory responses in the lungs, but the reduced inflammatory responses were not consistently associated with either improved or impaired bacterial elimination from the lungs. Our findings indicate that the inflammatory response to inhaled E. coli is TLR-4 dependent, but bacterial elimination depends on other factors in addition to TLR-4.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024722     DOI: 10.1152/ajplung.00196.2005

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  35 in total

1.  Toll-like receptors: a link between mechanical ventilation, innate immunity and lung injury?

Authors:  Pierre Emmanuel Charles; Saber Davide Barbar
Journal:  Intensive Care Med       Date:  2010-04-16       Impact factor: 17.440

2.  The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation.

Authors:  Janet S Lee; Mark M Wurfel; Gustavo Matute-Bello; Charles W Frevert; Matthew R Rosengart; Mrunalini Ranganathan; Venus W Wong; Tarah Holden; Steve Sutlief; Ann Richmond; Stephen Peiper; Thomas R Martin
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

3.  Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology.

Authors:  H A Banus; R J Vandebriel; H de Ruiter; J A M A Dormans; N J Nagelkerke; F R Mooi; B Hoebee; H J van Kranen; T G Kimman
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 4.  Innate immunity in the lungs.

Authors:  Thomas R Martin; Charles W Frevert
Journal:  Proc Am Thorac Soc       Date:  2005

5.  Influence of lipopolysaccharide-binding protein on pulmonary inflammation in gram-negative pneumonia.

Authors:  Michael A Taddonio; Vladislav Dolgachev; Markus Bosmann; Peter A Ward; Grace Su; Stewart C Wang; Mark R Hemmila
Journal:  Shock       Date:  2015-06       Impact factor: 3.454

6.  CX3CL1 up-regulation is associated with recruitment of CX3CR1+ mononuclear phagocytes and T lymphocytes in the lungs during cigarette smoke-induced emphysema.

Authors:  Jennifer G McComb; Mrunalini Ranganathan; Xiang Hong Liu; Joseph M Pilewski; Prabir Ray; Simon C Watkins; Augustine M K Choi; Janet S Lee
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

Review 7.  Pneumonia research to reduce childhood mortality in the developing world.

Authors:  J Anthony G Scott; W Abdullah Brooks; J S Malik Peiris; Douglas Holtzman; E Kim Mulholland
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 8.  Inhaled innate immune ligands to prevent pneumonia.

Authors:  Scott E Evans; Michael J Tuvim; Cory J Fox; Nidhi Sachdev; Leonid Gibiansky; Burton F Dickey
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

9.  Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin.

Authors:  Reuben Ramphal; Viviane Balloy; Jeevan Jyot; Amrisha Verma; Mustapha Si-Tahar; Michel Chignard
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice.

Authors:  Cecilia G Clement; Scott E Evans; Christopher M Evans; David Hawke; Ryuji Kobayashi; Paul R Reynolds; Seyed J Moghaddam; Brenton L Scott; Ernestina Melicoff; Roberto Adachi; Burton F Dickey; Michael J Tuvim
Journal:  Am J Respir Crit Care Med       Date:  2008-04-03       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.